Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BridgeBio Pharma Inc (BBIO) vs Nasdaq100 ETF (QQQ) Price & Performance

BridgeBio Pharma IncTrade
Nasdaq100 ETFTrade

Price performance (Past 24H)

Key statistics

BridgeBio Pharma Inc vs Nasdaq100 ETF — how do they compare? BridgeBio Pharma Inc trades at $83.9 (market cap $16.36B), while Nasdaq100 ETF trades at $722.81. Which is the better fit depends on your goals.

BBIOQQQ
Market Cap
$16.36B
Sector
Health
52-Week High
$90.17$746.16
52-Week Low
$47.29$558.34
Enterprise Value
$18.14B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About BridgeBio Pharma Inc

BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.

Read more on BBIO

About Nasdaq100 ETF

The ETF is designed to track the performance of the securities and the stocks in the NASDAQ-100 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.

Read more on QQQ